摘要
目的观察通心络治疗PCI术后心绞痛的疗效。方法将102例PCI术后心绞痛患者随机分为治疗组和对照组,对照组给予常规药物治疗,治疗组在常规治疗基础上加服通心络,治疗时间6个月,观察治疗前后心绞痛发作频率、心绞痛发作持续时间、左室射血分数(LVEF)及6min步行试验。另外记录患者服用通心络后的不良反应。结果治疗组治疗6个月后心绞痛疗效显著高于对照组(P<0.01),心绞痛发作频率、发作持续时间少于对照组(P<0.01),LVEF、6min步行试验显著优于对照组(P<0.05),且服用通心络后未见明显不良反应。结论通心络治疗PCI术后心绞痛能显著缓解心绞痛的发生,改善患者心功能。
Objective To observe curative effect of Tongxinluo in treatment of angina after percutaneous coronary intervention (PCI) operation. Methods 102 patients were randomly distributed treatment group and control group,it is used by common medicine treat- ment in control group, but it is used by Tongxinluo drug based on eordmon medicine treatment in treatment group, it is 6 monthes about survey time,it is observe indicator such as angina frequent duration time left ejection fraction (LVEF) and 6 minute walk test, and record side effct about tongxinluo drug. Results After 6 monthes, angina effect in treatment group was higer than that of control group ( P 〈 O. 01 ), angina frequent and duration times was less than that of control group( P 〈 0.01 ), and LVEF and 6 minute walk test was superior than that of control group (P 〈 0. 05 ). After treatment, it is less side effect in the treatment group. Conclusion It can remarkarble reduce angina by used tongxinluo after PCI operation angina,improve cardiac function.
出处
《中国医学创新》
CAS
2012年第5期9-10,共2页
Medical Innovation of China